New DNA test could spot uterine cancer from a urine sample
NCT ID NCT07400835
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether DNA markers in urine, vaginal, and cervical samples can better identify endometrial cancer risk in women with postmenopausal bleeding. About 600 participants will provide samples and undergo standard ultrasound. The goal is to see if these non-invasive tests can reduce unnecessary biopsies and catch cancer earlier.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ENDOMETRIAL CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Department of Obstetrics and Gynaecology, Aarhus University Hospital
RECRUITINGAarhus N, 8200, Denmark
-
Department of Obstetrics and Gynaecology, Odense University Hospital
RECRUITINGOdense, 5000, Denmark
-
Department of Obstetrics and Gynaecology, Randers Regional Hospital
NOT_YET_RECRUITINGRanders, 8930, Denmark
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug combo revive Immunotherapy's power against resistant tumors?
- What raises endometrial cancer risk in black women? a study digs in
- Can immunotherapy plus hormones spare the womb in early endometrial cancer?
- Can a new drug tackle Hard-to-Treat gynecologic cancers?
- Can a pill restore the Body's tumor suppressor to fight multiple cancers?
- Could gentle yoga and breathing ease Cancer's lingering toll?